Latest News and Press Releases

北卡罗来纳州夏洛特, May 01, 2026 (GLOBE NEWSWIRE) -- Sonablate 是一家专注于使用高强度聚焦超声 (HIFU) 开展无创前列腺癌治疗的医疗科技企业。该公司今日宣布，任命前 Stryker 医疗事业部总裁 Brad Saar 为董事会成员。Saar 的加盟表明，Sonablate 将持续推广采用...

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.

北卡罗来纳州夏洛特市, April 09, 2026 (GLOBE NEWSWIRE) -- 聚焦超声技术领域的全球领导者Sonablate今日宣布了其领导团队的重要新增成员任命，以扩大其“精准声波医学”的规模——利用靶向超声能量在不进行手术的情况下治疗疾病，同时保全患者的生活质量。 Martin (“Marty”) Wade 已获任董事会主席，Brian...

Sonablate announced leadership team additions as it scales “precision sound medicine” using targeted ultrasound energy to treat disease without surgery.

HIFIVE is a Phase I trial to assess the safety and performance of Sonablate high-intensity focused ultrasound for treating incompetent veins